non neoplastic cronic pain MedDRA version: 9.1 Level: PT Classification code 10033371 Term: Pain MedDRA version: 9.1 Level: PT Classification code 10050819 Term: Musculoskeletal chest pain
Conditions
Sponsors
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age between 60 and 75 years Persistent pain (≥ 3 months) of non-malignant etiology Median pain intensity in the last 7 days at least moderate Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Participation to other studies in the last 3 months Severe cognitive deterioration Refuse or inability to give consent Active cancer diagnosis On an analgesic medication for over 1 month Recent ( 1.5 mg/dl) Dialysis or kidney transplantation Recent (< 3 months) urinary retention Heart failure (NYHA class III-IV) Psychiatric disease Chronic hepatitis Respiratory failure (stadio GOLD II-III) Allergies or intolerance to study drugs Epilepsy or epileptic medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Primary ? comparative tolerability and safety of NSAIDs and tramadol once-a-day (OAD);Secondary Objective: comparative efficacy of NSAIDs and tramadol OAD;Primary end point(s): comparative tolerability and safety of NSAIDs and tramadol once-a-day (OAD) | — |
Countries
Italy
Outcome results
None listed